These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22526366)

  • 41. Infant mortality and reproductive wastage associated with different genotypes of haemoglobinopathies in Orissa, India.
    Balgir RS
    Ann Hum Biol; 2007; 34(1):16-25. PubMed ID: 17536752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example.
    Amato A; Grisanti P; Lerone M; Ponzini D; Di Biagio P; Cappabianca MP; Giordano PC
    Prenat Diagn; 2009 Dec; 29(12):1171-4. PubMed ID: 19816879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels.
    Gulbis B; Ferster A; Cotton F; Lebouchard MP; Cochaux P; Vertongen F
    J Med Screen; 2006; 13(2):76-8. PubMed ID: 16792829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prenatal diagnosis of haemoglobinopathies.
    Arora S; Kabra M; Maheshwari M; Shastri S; Kaur D; Deka D; Kriplani A; Menon PS
    Natl Med J India; 2001; 14(6):340-2. PubMed ID: 11804364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thalassaemia screening in a non-prevalent region of a prevalent country (Turkey): is it necessary?
    Acemoglu H; Beyhun NE; Vancelik S; Polat H; Guraksin A
    Public Health; 2008 Jun; 122(6):620-4. PubMed ID: 18222509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of thalassemia.
    Loukopoulos D; Kaltsoya-Tassiopoulou A; Fessas P
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1419-27. PubMed ID: 6316486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hospitalization of children with sickle cell disease in a region with increasing immigration rates.
    Colombatti R; Dalla Pozza LV; Mazzucato M; Sainati L; Pierobon M; Facchin P
    Haematologica; 2008 Mar; 93(3):463-4. PubMed ID: 18310539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling.
    Colah R; Surve R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Satoskar P; Mohanty D
    Prenat Diagn; 2005 May; 25(5):345-9. PubMed ID: 15906420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allogeneic transplantation for haemoglobinopathies.
    Vassiliou G; Amrolia P; Roberts IA
    Best Pract Res Clin Haematol; 2001 Dec; 14(4):807-22. PubMed ID: 11924923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of haemoglobinopathies in various populations - the impact of immigration.
    Henderson S; Timbs A; McCarthy J; Gallienne A; Van Mourik M; Masters G; May A; Khalil MS; Schuh A; Old J
    Clin Biochem; 2009 Dec; 42(18):1745-56. PubMed ID: 19497317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hémoglobinopathies in France.
    Labie D; Galacteros F; Girot R; Rosa J
    Nouv Rev Fr Hematol (1978); 1986; 28(4):253-5. PubMed ID: 3774536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal diagnosis of beta-thalassaemia and sickle cell anaemia in Turkey.
    Tüzmen S; Tadmouri GO; Ozer A; Baig SM; Ozçelik H; Başaran S; Başak AN
    Prenat Diagn; 1996 Mar; 16(3):252-8. PubMed ID: 8710780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deaths: final data for 1997.
    Hoyert DL; Kochanek KD; Murphy SL
    Natl Vital Stat Rep; 1999 Jun; 47(19):1-104. PubMed ID: 10410536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thalassaemia and haemoglobinopathies in Brunei Darussalam.
    Ismail JB
    Med J Malaysia; 1992 Jun; 47(2):98-102. PubMed ID: 1494340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secular trends in the national and provincial births of new thalassemia cases in Iran from 2001 to 2006.
    Dehshal MH; Ahmadvand A; Darestani SY; Manshadi M; Abolghasemi H
    Hemoglobin; 2013; 37(2):124-37. PubMed ID: 23470148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study.
    Giordano PC; Plancke A; Van Meir CA; Janssen CA; Kok PJ; Van Rooijen-Nijdam IH; Tanis BC; van Huisseling JC; Versteegh FG
    Prenat Diagn; 2006 Aug; 26(8):719-24. PubMed ID: 16752436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotype and genotype frequency of β-thalassemia and sickle cell disease carriers in Halkidiki, Northern Greece.
    Kalleas C; Anagnostopoulos K; Sinopoulou K; Delaki E; Margaritis D; Bourikas G; Tsatalas C; Kortsaris A; Tentes I
    Hemoglobin; 2012; 36(1):64-72. PubMed ID: 22188117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antenatal screening for couples at risk of having children with sickle cell disorders.
    Eboh W; Van den Akker O
    Midwives (1995); 1997 Feb; 110(1309):26-7. PubMed ID: 9128568
    [No Abstract]   [Full Text] [Related]  

  • 59. Prevention and control of haemoglobinopathies.
    Angastiniotis M; Modell B; Englezos P; Boulyjenkov V
    Bull World Health Organ; 1995; 73(3):375-86. PubMed ID: 7614670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deaths: final data for 2000.
    Miniño AM; Arias E; Kochanek KD; Murphy SL; Smith BL
    Natl Vital Stat Rep; 2002 Sep; 50(15):1-119. PubMed ID: 12382630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.